Primary oligodendrocyte death does not elicit anti-CNS immunity
- 26 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Neuroscience
- Vol. 15 (4), 543-550
- https://doi.org/10.1038/nn.3062
Abstract
Anti-myelin immunity is commonly thought to drive multiple sclerosis, yet the initial trigger of this autoreactivity remains elusive. One of the proposed factors for initiating this disease is the primary death of oligodendrocytes. To specifically test such oligodendrocyte death as a trigger for anti-CNS immunity, we inducibly killed oligodendrocytes in an in vivo mouse model. Strong microglia-macrophage activation followed oligodendrocyte death, and myelin components in draining lymph nodes made CNS antigens available to lymphocytes. However, even conditions favoring autoimmunity-bystander activation, removal of regulatory T cells, presence of myelin-reactive T cells and application of demyelinating antibodies-did not result in the development of CNS inflammation after oligodendrocyte death. In addition, this lack of reactivity was not mediated by enhanced myelin-specific tolerance. Thus, in contrast with previously reported impairments of oligodendrocyte physiology, diffuse oligodendrocyte death alone or in conjunction with immune activation does not trigger anti-CNS immunity.Keywords
This publication has 53 references indexed in Scilit:
- IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in miceJCI Insight, 2008
- Multiple sclerosisThe Lancet, 2008
- MHC class II exacerbates demyelination in vivo independently of T cellsJournal of Neuroimmunology, 2008
- Microglial Recruitment, Activation, and Proliferation in Response to Primary DemyelinationThe American Journal of Pathology, 2007
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007
- Identification of genes preferentially expressed by microglia and upregulated during cuprizone‐induced inflammationGlia, 2007
- Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Evolution of a neuroprotective function of central nervous system myelinThe Journal of cell biology, 2006
- Use of Suppression Subtractive Hybridization for Differential Gene Expression in StrokeStroke, 2001
- Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosisAnnals of Neurology, 1998